XAPASS: Evidence of Safety and Effectiveness in Japanese Patients Treated with Rivaroxaban for Stroke Prevention in Atrial Fibrillation under Real-World Clinical Practice
Identifying patients with atrial fibrillation and "truly low" thromboembolic risk who are poorly characterized by CHA2DS2-VASc: Superior performance of a novel machine learning tool in GARFIELD-AF
ESC-EURObservational Research Programme: In-hospital and 1-year follow-up of the Long-term Atrial Fibrillation Ablation Registry, Conducted by the European Heart Rhythm Association
Speaker:
Associate Professor E. Arbelo (Barcelona, ES)
A Large-Scale Multi-Center Registry of Patients Undergoing Radiofrequency Catheter Ablation for Atrial Fibrillation: Kansai Plus Atrial Fibrillation Study